tDCS Clinical Trials
2 recruiting trials for tDCS. Eligibility criteria explained in plain English.
TrialFinderData lists 2 tDCS clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Centre Hospitalier Universitaire, Amiens (1), Jiangsu Province Nanjing Brain Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is transcranial electrical stimulation therapy (other, 1 trial), followed by Active HD-tDCS, Antipsychotics, mood stabilizers, etc..
Track tDCS trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Optimized and Personalized Trans-cranial Brain Stimulation in Partial Refractory Epilepsies
Epilepsy is one of the most common neurological diseases, affecting between 0.5% and 1% of the general population. Therefore, new diagnostic and treatment methods are having a big...
HD-tDCS for Adolescent Bipolar Depression Targeting S1
This randomized, double-blind, sham-controlled clinical trial aims to evaluate the efficacy and underlying biological mechanisms of HD-tDCS targeting the primary somatosensory...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for tDCS, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for tDCS, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for tDCS, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.